181 related articles for article (PubMed ID: 38493200)
1. Application of droplet digital PCR in minimal residual disease monitoring of rare fusion transcripts and mutations in haematological malignancies.
Ip BBK; Wong ATC; Law JHY; Au CH; Ma SY; Chim JCS; Liang RHS; Leung AYH; Wan TSK; Ma ESK
Sci Rep; 2024 Mar; 14(1):6400. PubMed ID: 38493200
[TBL] [Abstract][Full Text] [Related]
2. Methods of minimal residual disease (MRD) detection in childhood haematological malignancies.
Jółkowska J; Derwich K; Dawidowska M
J Appl Genet; 2007; 48(1):77-83. PubMed ID: 17272865
[TBL] [Abstract][Full Text] [Related]
3. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia.
van Dongen JJ; Macintyre EA; Gabert JA; Delabesse E; Rossi V; Saglio G; Gottardi E; Rambaldi A; Dotti G; Griesinger F; Parreira A; Gameiro P; Diáz MG; Malec M; Langerak AW; San Miguel JF; Biondi A
Leukemia; 1999 Dec; 13(12):1901-28. PubMed ID: 10602411
[TBL] [Abstract][Full Text] [Related]
4. Fusion gene transcripts and Ig/TCR gene rearrangements are complementary but infrequent targets for PCR-based detection of minimal residual disease in acute myeloid leukemia.
Boeckx N; Willemse MJ; Szczepanski T; van der Velden VH; Langerak AW; Vandekerckhove P; van Dongen JJ
Leukemia; 2002 Mar; 16(3):368-75. PubMed ID: 11896540
[TBL] [Abstract][Full Text] [Related]
5. [The current status of genetic testing for leukemia].
Satoh Y; Masuda A; Yokota H; Yatomi Y
Rinsho Byori; 2014 Apr; 62(4):369-77. PubMed ID: 25022066
[TBL] [Abstract][Full Text] [Related]
6. Large amplicon droplet digital PCR for DNA-based monitoring of pediatric chronic myeloid leukaemia.
Krumbholz M; Goerlitz K; Albert C; Lawlor J; Suttorp M; Metzler M
J Cell Mol Med; 2019 Aug; 23(8):4955-4961. PubMed ID: 31199062
[TBL] [Abstract][Full Text] [Related]
7. A method to identify new molecular markers for assessing minimal residual disease in acute leukemia patients.
Jancuskova T; Plachy R; Stika J; Zemankova L; Hardekopf DW; Liehr T; Kosyakova N; Cmejla R; Zejskova L; Kozak T; Zak P; Zavrelova A; Havlikova P; Karas M; Junge A; Ramel C; Pekova S
Leuk Res; 2013 Oct; 37(10):1363-73. PubMed ID: 23870092
[TBL] [Abstract][Full Text] [Related]
8. Status of minimal residual disease testing in childhood haematological malignancies.
Campana D
Br J Haematol; 2008 Nov; 143(4):481-9. PubMed ID: 18710378
[TBL] [Abstract][Full Text] [Related]
9. Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects.
van der Velden VH; Hochhaus A; Cazzaniga G; Szczepanski T; Gabert J; van Dongen JJ
Leukemia; 2003 Jun; 17(6):1013-34. PubMed ID: 12764363
[TBL] [Abstract][Full Text] [Related]
10. PCR for monitoring of minimal residual disease in hematologic malignancy.
Matsuda K; Sugano M; Honda T
Clin Chim Acta; 2012 Jan; 413(1-2):74-80. PubMed ID: 22057038
[TBL] [Abstract][Full Text] [Related]
11. A new highly sensitive real-time quantitative-PCR method for detection of BCR-ABL1 to monitor minimal residual disease in chronic myeloid leukemia after discontinuation of imatinib.
Kitamura H; Tabe Y; Ai T; Tsuchiya K; Yuri M; Misawa S; Horii T; Kawaguchi A; Ohsaka A; Kimura S
PLoS One; 2019; 14(3):e0207170. PubMed ID: 30835732
[TBL] [Abstract][Full Text] [Related]
12. Digital PCR: A Reliable Tool for Analyzing and Monitoring Hematologic Malignancies.
Coccaro N; Tota G; Anelli L; Zagaria A; Specchia G; Albano F
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32365599
[TBL] [Abstract][Full Text] [Related]
13. Applicability of droplet digital polymerase chain reaction for minimal residual disease monitoring in Philadelphia-positive acute lymphoblastic leukaemia.
Ansuinelli M; Della Starza I; Lauretti A; Elia L; Siravo V; Messina M; De Novi LA; Taherinasab A; Canichella M; Guarini A; Foà R; Chiaretti S
Hematol Oncol; 2021 Dec; 39(5):680-686. PubMed ID: 34402088
[TBL] [Abstract][Full Text] [Related]
14. Molecular diagnosis of hematopoietic and lymphoid neoplasms.
Jevremovic D; Viswanatha DS
Hematol Oncol Clin North Am; 2009 Aug; 23(4):903-33. PubMed ID: 19577174
[TBL] [Abstract][Full Text] [Related]
15. An update on PCR use for minimal residual disease monitoring in acute lymphoblastic leukemia.
Nunes V; Cazzaniga G; Biondi A
Expert Rev Mol Diagn; 2017 Nov; 17(11):953-963. PubMed ID: 28891364
[TBL] [Abstract][Full Text] [Related]
16. Droplet Digital PCR Is a Reliable Tool for Monitoring Minimal Residual Disease in Acute Promyelocytic Leukemia.
Brunetti C; Anelli L; Zagaria A; Minervini A; Minervini CF; Casieri P; Coccaro N; Cumbo C; Tota G; Impera L; Orsini P; Specchia G; Albano F
J Mol Diagn; 2017 May; 19(3):437-444. PubMed ID: 28268092
[TBL] [Abstract][Full Text] [Related]
17. Detection of minimal residual disease in acute leukemia patients.
van Dongen JJ; Szczepański T; de Bruijn MA; van den Beemd MW; de Bruin-Versteeg S; Wijkhuijs JM; Tibbe GJ; van Gastel-Mol EJ; Groeneveld K; Hooijkaas H
Cytokines Mol Ther; 1996 Jun; 2(2):121-33. PubMed ID: 9384697
[TBL] [Abstract][Full Text] [Related]
18. Use of Droplet Digital Polymerase Chain Reaction for Detecting Minimal Residual Disease: A Prospective Multi-Institutional Study.
Park H; Shin DY; Kim I; Sohn SK; Koh Y; Lee JH; Lee KH; Kim DY; Kim HJ; Ahn JS; Lee JO; Bang SM; Cheong JW; Park SG; Park S; Lee YJ; Ahn SY
In Vivo; 2019; 33(6):2273-2280. PubMed ID: 31662567
[TBL] [Abstract][Full Text] [Related]
19. Comparison of minimal residual disease measurement by multicolour flow cytometry and PCR for fusion gene transcripts in infants with acute lymphoblastic leukaemia with KMT2A gene rearrangements.
Popov A; Tsaur G; Verzhbitskaya T; Riger T; Permikin Z; Demina A; Mikhailova E; Shorikov E; Arakaev O; Streneva O; Khlebnikova O; Makarova O; Miakova N; Fominikh V; Boichenko E; Kondratchik K; Ponomareva N; Novichkova G; Karachunskiy A; Fechina L
Br J Haematol; 2023 May; 201(3):510-519. PubMed ID: 34970734
[TBL] [Abstract][Full Text] [Related]
20. Droplet Digital PCR Is a Robust Tool for Monitoring Minimal Residual Disease in Adult Philadelphia-Positive Acute Lymphoblastic Leukemia.
Coccaro N; Anelli L; Zagaria A; Casieri P; Tota G; Orsini P; Impera L; Minervini A; Minervini CF; Cumbo C; Parciante E; Carluccio P; Brunetti C; Specchia G; Albano F
J Mol Diagn; 2018 Jul; 20(4):474-482. PubMed ID: 29625246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
